chr5-70951938-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_000344.4(SMN1):c.835-3C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,460,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000344.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMN1 | NM_000344.4 | c.835-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000380707.9 | NP_000335.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMN1 | ENST00000380707.9 | c.835-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000344.4 | ENSP00000370083 | P1 |
Frequencies
GnomAD3 genomes Cov.: 27
GnomAD3 exomes AF: 0.00000806 AC: 2AN: 248152Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134482
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460496Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 726636
GnomAD4 genome Cov.: 27
ClinVar
Submissions by phenotype
Spinal muscular atrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 14, 2022 | For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with altered splicing resulting in unknown protein product impact (PMID: 21542063, 31213135). ClinVar contains an entry for this variant (Variation ID: 495829). This variant has been observed in individual(s) with spinal muscular atrophy (SMA) (PMID: 21542063; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. The frequency data for this variant in the population databases (gnomAD) is considered unreliable due to the presence of homologous sequence, such as pseudogenes or paralogs, in the genome. This sequence change falls in intron 7 of the SMN1 gene. It does not directly change the encoded amino acid sequence of the SMN1 protein. It affects a nucleotide within the consensus splice site. - |
Spinal muscular atrophy, type IV Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostics Lab, Nemours Children's Health, Delaware | Mar 02, 2016 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 26, 2021 | Variant summary: SMN1 c.835-3C>T alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, at least two functional studies report this variant produced aberrant transcripts (Vezain_2011, Soucek_2019). Additionally, Vezain_2011 showed that this variant leads to 20% of exon 7 skipping in SMN1 mRNA using a minigene assay. This study showed full length/exon7 skipped SMN1 mRNA ratio of 1.8 in a patient with mild SMA phenotype (who also carries an exon 7 deletion allele), which is higher than the positive controls with no SMN1 copy (1) and lower than the healthy controls with one SMN1 copy (2.4). These results further demonstrate that the variant of interest induces exon 7 skipping. However, the pathogenic role of this effect is not clear due to small sample size of patients and lack of additional functional studies. The variant allele was found at a frequency of 8.1e-06 in 248152 control chromosomes (gnomAD). Two ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance and pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 25, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at